Volitionrx (VNRX) Total Liabilities (2011 - 2025)

Volitionrx (VNRX) has 12 years of Total Liabilities data on file, last reported at $42.5 million in Q4 2025.

• For the quarter ending Q4 2025, Total Liabilities rose 19.68% year-over-year to $42.5 million; the trailing twelve-month figure through Dec 2025 stood at $42.5 million (up 19.68% YoY), and the FY2025 full-year result was $42.5 million, up 19.68% from the prior year.
• Total Liabilities for Q4 2025 stood at $42.5 million, roughly flat from $42.4 million in the prior quarter.
• Across five years, Total Liabilities topped out at $42.5 million in Q4 2025 and bottomed at -$31.2 million in Q1 2021.
• The 5-year median for Total Liabilities is $21.9 million (2022), against an average of $24.4 million.
• The widest annual swing landed in 2021, when Total Liabilities slumped 505.26%; it then surged 166.98% in 2022.
• A 5-year view of Total Liabilities shows it stood at $9.8 million in 2021, then soared by 119.3% to $21.4 million in 2022, then soared by 71.15% to $36.7 million in 2023, then fell by 3.15% to $35.5 million in 2024, then increased by 19.68% to $42.5 million in 2025.
• The last three Total Liabilities figures came in at $42.5 million (Q4 2025), $42.4 million (Q3 2025), and $41.8 million (Q2 2025), per Business Quant data.

Peer Comparison